Safety and efficacy of a new covered stent in hemodialysis vascular access outflow stenosis: A Brazilian multicenter retrospective study.

BACKGROUND: Vascular stenosis commonly leads to dysfunction in hemodialysis vascular access. Although percutaneous transluminal angioplasty is an established treatment, stent utilization has increased in the last decade as an alternative solution to extend the access function. This study evaluated the safety and initial results of a new impermeable covered stent for treating vascular access outflow stenosis. METHODS: Investigators retrospectively analyzed 114 hemodialysis patients treated with polytetrafluorethylene-covered stents from September 2018 to September 2022 across four centers. Lesions treated were de novo or restenotic and located in the venous graft anastomosis, outflow segment, cephalic arch, and basilic swing point. Patients were followed by in-person physical examination at 1, 3, and 6 months, and Duplex ultrasound was performed to evaluate the vascular access circuit and in-stent restenosis. The primary efficacy endpoint was target lesion primary patency at 1, 3, and 6 months. Secondary endpoints included access circuit primary patency and secondary patency at 1, 3, and 6 months. The primary safety endpoint was freedom from local or systemic serious adverse events through 30 days post-procedure. RESULTS: Forty-four patients had thrombosed access at the initial presentation, and 41 patients presented with recurrent stenosis. The target lesion primary patency rates at 1, 3, and 6 months were 100%, 89.4%, and 74%, respectively. The access circuit primary patency rates were 100% at 1 month, 85% at 3 months, and 62.7% at 6 months. The secondary patency rates at 1, 3, and 6 months were 100%, 96.4%, and 94.6%, respectively. In the adjusted multivariate Cox regression analysis, only recurrent lesions and female gender were associated with reduced primary patency rates. No serious adverse event was observed through the first 30 days post-procedure. CONCLUSION: In this retrospective analysis, a new covered stent was shown to be safe and effective for treating peripheral outflow stenosis in vascular access.

Guidelines on vascular access for hemodialysis from the Brazilian Society of Angiology and Vascular Surgery.

Chronic kidney disease is a worldwide public health problem, and end-stage renal disease requires dialysis. Most patients requiring renal replacement therapy have to undergo hemodialysis. Therefore, vascular access is extremely important for the dialysis population, directly affecting the quality of life and the morbidity and mortality of this patient population. Since making, managing and salvaging of vascular accesses falls within the purview of the vascular surgeon, developing guideline to help specialists better manage vascular accesses for hemodialysis if of great importance. Thus, the objective of this guideline is to present a set of recommendations to guide decisions involved in the referral, evaluation, choice, surveillance and management of complications of vascular accesses for hemodialysis.

A doença renal crônica é um problema de saúde pública global e em seu estágio terminal está associada à necessidade de terapia dialítica. A grande maioria dos pacientes que necessitam realizar a terapia renal substitutiva, a fazem através da hemodiálise. Portanto, o acesso vascular é de extrema importância para a população dialítica, implicando diretamente na qualidade de vida e na morbimortalidade deste grupo de pacientes. Sendo a confecção, gerenciamento e resgate dos acessos vasculares uma das áreas de atuação do cirurgião vascular, é de grande importância a elaboração de uma diretriz que oriente o especialista no manejo mais adequado do acesso vascular para hemodiálise. Assim, o objetivo desta diretriz é apresentar um conjunto de recomendações para guiar as decisões na referenciação, avaliação, escolha, vigilância e gestão das complicações do acesso vascular para hemodiálise.

Oversized balloon angioplasty for endovascular maturation of arteriovenous fistulae to accelerate cannulation and to decrease the duration of catheter use.

BACKGROUND: The functional autologous arteriovenous fistula is considered the best vascular access for patients on hemodialysis. Some fistulae exhibit maturation problems after creation and do not reach adequate vessel diameter and flow in dialysis. The aim of this study was to describe our technique of oversized balloon angioplasty for assisted maturation of arteriovenous fistulae to accelerate the cannulation and to decrease the time of catheter use and its outcome. METHODS: A retrospective analysis of balloon-assisted procedures for maturation failure was performed in a single center between October 2011 and January 2019. Patients underwent imaging procedures to identify stenosis, followed by angioplasty using oversized high-pressure balloons from the anastomosis to the deep venous outflow tract. The flow volume, time interval of use of the fistula and removal of the catheter, patency rates, and complications rates were evaluated. RESULTS: Seventy-eight patients underwent 124 balloon angioplasty procedures. Technical and clinical success was achieved in 91% of the cases. In patients in whom maturation was successful, the fistula was cannulated in a mean time of 5 days after the procedure (range, 1-20 days). On average, catheter removal was performed 14 days (range, 5-33 days) after the maturation procedure. The mean flow volume in the fistula before the procedure was 276 ml/min (range, 122-488 ml/min) and 24 h after the maturation was 1014 ml/min (range, 760-1800 ml/min).The primary patency rate at 3, 6, and 12 months was 87.3%, 66.2%, and 50.7%, respectively. Assisted primary patency was 100% at 3 months, 92.9% at 6 months, and 90.0% at 12 months. Minor complications occurred in 18% of cases, and major complications in 4.8%. CONCLUSIONS: The oversized balloon-assisted arteriovenous fistula maturation technique is safe and effective, allowing the cannulation of the fistulae a few hours or days after the procedure and decreasing the time of catheter use.

Guidelines on vascular access for hemodialysis from the Brazilian Society of Angiology and Vascular Surgery / Diretrizes sobre acesso vascular para hemodiálise da Sociedade Brasileira de Angiologia e de Cirurgia Vascular

Abstract Chronic kidney disease is a worldwide public health problem, and end-stage renal disease requires dialysis. Most patients requiring renal replacement therapy have to undergo hemodialysis. Therefore, vascular access is extremely important for the dialysis population, directly affecting the quality of life and the morbidity and mortality of this patient population. Since making, managing and salvaging of vascular accesses falls within the purview of the vascular surgeon, developing guideline to help specialists better manage vascular accesses for hemodialysis if of great importance. Thus, the objective of this guideline is to present a set of recommendations to guide decisions involved in the referral, evaluation, choice, surveillance and management of complications of vascular accesses for hemodialysis.

Resumo A doença renal crônica é um problema de saúde pública global e em seu estágio terminal está associada à necessidade de terapia dialítica. A grande maioria dos pacientes que necessitam realizar a terapia renal substitutiva, a fazem através da hemodiálise. Portanto, o acesso vascular é de extrema importância para a população dialítica, implicando diretamente na qualidade de vida e na morbimortalidade deste grupo de pacientes. Sendo a confecção, gerenciamento e resgate dos acessos vasculares uma das áreas de atuação do cirurgião vascular, é de grande importância a elaboração de uma diretriz que oriente o especialista no manejo mais adequado do acesso vascular para hemodiálise. Assim, o objetivo desta diretriz é apresentar um conjunto de recomendações para guiar as decisões na referenciação, avaliação, escolha, vigilância e gestão das complicações do acesso vascular para hemodiálise.

Case report: Arteriovenous graft for hemodialysis using abdominal vessels.

The improvement of dialysis therapy and clinical support has increased the life expectancy of patients with end stage renal disease (ESRD) over the last years. However, in Brazil, the renal transplant rate cannot follow this growth. This fact, in association with the unavailability of adequate healthcare services in the country, substantially enlarges the use of dual lumen catheters and, consequently, access-related complications. The result is a high rate of patients with access failure, which brings a challenge: how to maintain dialysis in this group? This case report describes a non-conventional surgical approach to create a definite access using abdominal vessels, in an end stage vascular access patient.

A FDG-18F na distinção de placa aterosclerótica: inovação em tecnologia PET/CT / FDG-18F in differentiating atherosclerotic plaque: innovation in PET/CT technology

A composição da placa aterosclerótica, em contrapartida ao grau de estenose arterial, parece ser o determinante crítico da vulnerabilidade e trombogenicidade da placa. O fluordesoxiglucose (FDG-18F), pode ser usado para obter imagensda atividade celular inflamatória de forma não invasiva através da tecnología PET. O objetivo principal do presente estudo foi averiguar a viabilidade da tecnologia FDG-18F PET na avaliação do processo inflamatório instalado nas placas ateroscleróticas, e, dessa forma, promover a distinção de placas ateroscleróticas através da relação entre acúmulo do radiofármaco e as características funcionais da lesão aterosclerótica. Estudo epidemiológico prospectivo, duplo cego randomizado, transversal foi realizado em cinco pacientes, seis controles e, os mesmos, foram submetidos ao exame diagnóstico FDG-18F PET/CT. Os valores de suv em artérias carótidas e veias jugulares do próprio paciente e o comparativo com o grupo controle foram correlacionados através de uma avaliação qualitativa do coeficiente de correlação de pearson. Através de um estudo descritivo comparativo inter-grupos na carótida direita observa-se que 64.9% da média dos valores de SUV corresponde aos pacientes em estudo. Na análise efetuada intra-grupo da carótida direita com a jugular direita dos pacientes em estudo, observou-se um valor médio de SUV 26.2% superior na artéria carótida. No grupo controle, a diferença entre os níveis médios de captação do FDG-18F foi inferior a 10%. Através da endarterectomia, foi possível realizar um estudo anátomo patológico e, dessa forma, identificar a presença de conteúdo inflamatórionas carótidas avaliadas, caracterizando assim placas instáveis. A tecnologia FDG-18F PET mostrou-se exequível favorecendo uma boa correlação histopatológica entre o processo inflamatório instalado nas placas ateroscleróticas e os níveis mensurados de SUV.

An ethological approach to the study of behavioral disorders provides key information on functionalaspects of behavior that characterize certain pathologies. The purpose of this study was to describe non-verbal behavioral units presented by a group of 14 women with social phobia (SP) and a control groupof 13 women during a clinical interview and to evaluate the possible differences between these twogroups. The 19 behavior units were selected with the index of concordance between the observers tauKendall = 0.795 (p = 0.000). People with SP supported the way they spoke with their hands and placedtheir hands on their legs, in comparison with the control group. People with SP nodded more often,touched their faces, pressed their lips, licked their lips and touched their hair more frequently than thecontrol group. The article suggests that a systematic evaluation of non-verbal behavior may be impor-tant in conducting a full evaluation of patients with SF in a clinical environment, and may contribute toevaluating the efficiency of the treatment.

A FDG-18F na distinþÒo de placa aterosclerótica: inovaþÒo em tecnologia PET/CT / FDG-18F in differentiating atherosclerotic plaque: innovation in PET/CT technology

A composiþÒo da placa aterosclerótica, em contrapartida ao grau de estenose arterial, parece ser o determinante crítico da vulnerabilidade e trombogenicidade da placa. O fluordesoxiglucose (FDG-18F), pode ser usado para obter imagensda atividade celular inflamatória de forma nÒo invasiva através da tecnología PET. O objetivo principal do presente estudo foi averiguar a viabilidade da tecnologia FDG-18F PET na avaliaþÒo do processo inflamatório instalado nas placas ateroscleróticas, e, dessa forma, promover a distinþÒo de placas ateroscleróticas através da relaþÒo entre acúmulo do radiofármaco e as características funcionais da lesÒo aterosclerótica. Estudo epidemiológico prospectivo, duplo cego randomizado, transversal foi realizado em cinco pacientes, seis controles e, os mesmos, foram submetidos ao exame diagnóstico FDG-18F PET/CT. Os valores de suv em artérias carótidas e veias jugulares do próprio paciente e o comparativo com o grupo controle foram correlacionados através de uma avaliaþÒo qualitativa do coeficiente de correlaþÒo de pearson. Através de um estudo descritivo comparativo inter-grupos na carótida direita observa-se que 64.9% da média dos valores de SUV corresponde aos pacientes em estudo. Na análise efetuada intra-grupo da carótida direita com a jugular direita dos pacientes em estudo, observou-se um valor médio de SUV 26.2% superior na artéria carótida. No grupo controle, a diferenþa entre os níveis médios de captaþÒo do FDG-18F foi inferior a 10%. Através da endarterectomia, foi possível realizar um estudo anátomo patológico e, dessa forma, identificar a presenþa de conteúdo inflamatórionas carótidas avaliadas, caracterizando assim placas instáveis. A tecnologia FDG-18F PET mostrou-se exequível favorecendo uma boa correlaþÒo histopatológica entre o processo inflamatório instalado nas placas ateroscleróticas e os níveis mensurados de SUV. (AU)

An ethological approach to the study of behavioral disorders provides key information on functionalaspects of behavior that characterize certain pathologies. The purpose of this study was to describe non-verbal behavioral units presented by a group of 14 women with social phobia (SP) and a control groupof 13 women during a clinical interview and to evaluate the possible differences between these twogroups. The 19 behavior units were selected with the index of concordance between the observers tauKendall = 0.795 (p = 0.000). People with SP supported the way they spoke with their hands and placedtheir hands on their legs, in comparison with the control group. People with SP nodded more often,touched their faces, pressed their lips, licked their lips and touched their hair more frequently than thecontrol group. The article suggests that a systematic evaluation of non-verbal behavior may be impor-tant in conducting a full evaluation of patients with SF in a clinical environment, and may contribute toevaluating the efficiency of the treatment.(AU)